Archive - June 2023
FDA approves Pfizer's LITFULO™ (ritlecitinib) for adults and adolescents with severe alopecia areata
Magdeburg researchers discover a new mechanism of cancer immune defense
Optimize next best action tools to deliver value-based engagement
FDA Approves Litfulo (ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata
FDA Approves Elevidys (delandistrogene moxeparvovec-rokl) Gene Therapy to Treat Duchenne Muscular Dystrophy
FDA approves first gene therapy for treatment of certain patients with Duchenne muscular dystrophy
FDA Approves Suflave (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride) Colonoscopy Preparation that Tastes Similar to a Sports Drink
FDA Approves Jardiance (empagliflozin) for the Treatment of Type 2 Diabetes in Children 10 Years and Older